Yuan Zhang | Pharmaceutical Sciences | Best Researcher Award

Posted on by usudeeparya

Prof. Yuan Zhang | Pharmaceutical Sciences | Best Researcher Award

Deputy Director at South China University of Technology, China📖

Dr. Yuan Zhang is a distinguished professor at South China University of Technology, where he serves in the School of Biomedical Sciences and Engineering at the Guangzhou International Campus. Additionally, he contributes to the National Engineering Research Center for Tissue Restoration and Reconstruction. With a career marked by groundbreaking research in pharmaceutical sciences and nanotechnology, Dr. Zhang has established himself as a leading figure in drug delivery systems and cancer research.

Profile

Google Scholar Profile

Education Background🎓

Dr. Zhang completed his postdoctoral research fellowship at the Massachusetts Institute of Technology (MIT) from 2013 to 2016, under the mentorship of Prof. Darrell J. Irvine, a National Academy of Medicine member and Howard Hughes Medical Institute (HHMI) investigator. He earned his Ph.D. in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill in 2013, where he specialized in molecular pharmaceutics and nanotechnology. Before this, he received his M.S. in Pharmaceutical Sciences from Peking University in 2009, guided by Prof. Qiang Zhang, a member of the Chinese Academy of Engineering. Dr. Zhang also holds dual bachelor’s degrees in Pharmaceutical Sciences and Economics from Peking University.

Professional Experience🌱

Dr. Zhang began his academic career as an Assistant Professor at the University of Rhode Island from 2016 to 2019, where he excelled in advancing biomedical and pharmaceutical sciences. Since 2019, he has been a professor at South China University of Technology, contributing significantly to research in tissue restoration and reconstruction while mentoring the next generation of scientists.

Research Interests🔬

Dr. Zhang’s research focuses on nanotechnology for drug delivery, tissue engineering, and cancer therapy. He explores innovative approaches to enhance the efficacy and precision of drug delivery systems, emphasizing translational research to improve patient outcomes. His contributions to molecular pharmaceutics and tissue restoration have opened new avenues in biomedical sciences, particularly in regenerative medicine and targeted therapeutics.

Author Metrics

Dr. Zhang’s research has led to numerous high-impact publications in leading journals, reflecting his expertise in drug delivery systems, nanotechnology, and cancer therapeutics. His work is widely cited, underscoring his influence and thought leadership in pharmaceutical sciences.

Publications Top Notes 📄

1. In Vivo Gene Delivery by Nonviral Vectors: Overcoming Hurdles

Authors: Y. Zhang, A. Satterlee, L. Huang
Journal: Molecular Therapy, 2012, 20(7), pp. 1298–1304
Citations: 470
Summary:
This paper discusses the challenges of in vivo gene delivery using nonviral vectors, emphasizing strategies to overcome barriers such as stability, targeting efficiency, and cellular uptake. The study highlights advancements in nanotechnology and biomaterials that enhance the potential of nonviral vectors for clinical applications in gene therapy.

2. Delivering Safer Immunotherapies for Cancer

Authors: L. Milling, Y. Zhang, D.J. Irvine
Journal: Advanced Drug Delivery Reviews, 2017, 114, pp. 79–101
Citations: 305
Summary:
The paper reviews recent developments in cancer immunotherapies, focusing on minimizing systemic toxicity while enhancing efficacy. It explores strategies such as targeted delivery systems, immune checkpoint inhibitors, and nanocarriers to ensure safer and more effective immunotherapy solutions.

3. Nanoparticle Anchoring Targets Immune Agonists to Tumors Enabling Anti-Cancer Immunity Without Systemic Toxicity

Authors: Y. Zhang, N. Li, H. Suh, D.J. Irvine
Journal: Nature Communications, 2018, 9(1), Article 6
Citations: 215
Summary:
This study introduces a novel nanoparticle system for targeting immune agonists directly to tumors, thereby inducing a potent anti-cancer immune response. The method reduces systemic toxicity and enhances the therapeutic index of immune-based treatments, representing a breakthrough in cancer immunotherapy.

4. Biomimetic Diselenide‐Bridged Mesoporous Organosilica Nanoparticles as an X‐Ray‐Responsive Biodegradable Carrier for Chemo‐Immunotherapy

Authors: D. Shao, F. Zhang, F. Chen, X. Zheng, H. Hu, C. Yang, Z. Tu, Z. Wang, Y. Zhang, et al.
Journal: Advanced Materials, 2020, 32(50), Article 2004385
Citations: 199
Summary:
The paper presents innovative mesoporous organosilica nanoparticles with diselenide bridges for X-ray-triggered chemo-immunotherapy. These nanoparticles are biodegradable, providing a controlled drug release system that combines chemotherapy and immunotherapy for enhanced anti-cancer efficacy.

5. Lipid-Coated Cisplatin Nanoparticles Induce Neighboring Effect and Exhibit Enhanced Anticancer Efficacy

Authors: S. Guo, Y. Wang, L. Miao, Z. Xu, C.M. Lin, Y. Zhang, L. Huang
Journal: ACS Nano, 2013, 7(11), pp. 9896–9904
Citations: 145
Summary:
This research develops lipid-coated cisplatin nanoparticles that induce a “neighboring effect,” enhancing anticancer efficacy. The study demonstrates the nanoparticles’ ability to selectively target cancer cells, improve drug delivery, and minimize off-target toxicity, making them a promising candidate for advanced chemotherapy.

Conclusion

Dr. Yuan Zhang exemplifies the qualities of an outstanding researcher, with groundbreaking contributions to pharmaceutical sciences and nanotechnology. His work has significantly advanced the fields of drug delivery, cancer therapy, and tissue restoration, earning him high citation metrics and global recognition. By focusing more on translational research, interdisciplinary collaborations, and public engagement, Dr. Zhang could further amplify the real-world impact of his innovations.

Given his achievements, leadership roles, and potential for future contributions, Dr. Zhang is a highly suitable candidate for the Best Researcher Award, making him a deserving recipient of this prestigious honor.

Zahra Barati | epidemiology | Best Researcher Award

Posted on by usudeeparya

Ms. Zahra Barati | epidemiology | Best Researcher Award

Zahra Barati at  Isfahan University of Medical Sciences, Isfahan, Iran📝

Zahra Barati is a skilled epidemiologist with a strong foundation in public health research and statistical analysis. She has demonstrated excellence in academic achievements, teaching, and leadership within her field. As a distinguished student and a dedicated researcher, Zahra has contributed to significant research in infectious disease epidemiology, including a recent thesis on bovine brucellosis, and has received multiple recognitions for her academic and professional contributions.

Profile    

Orcid Profile

Education 🎓

Zahra Barati holds a Master’s degree in Epidemiology (MSc) from the School of Health, Isfahan University of Medical Sciences, completed in February 2024. Her thesis, supervised by Professor Shahrokh Izadi, focused on “Bovine Brucellosis, Associated Risk Factors, and Preventive Measures in Industrial Cattle Farms.” During her master’s program, Zahra acquired extensive knowledge in epidemiology and biostatistics, covering topics such as epidemiological methods, statistical methods in epidemiology, and the epidemiology of infectious and non-communicable diseases. She completed her Bachelor’s degree in Public Health at Semnan University of Medical Sciences, Iran, in June 2016.

Professional Experience 💼

Zahra has been actively involved in teaching, research, and leadership roles throughout her academic journey. She instructed undergraduate students in public health internship courses at Semnan University of Medical Sciences. Additionally, she served as Secretary of the Epidemiology and Biostatistics Student Scientific Association at Isfahan University of Medical Sciences, leading workshops and activities for two years. Her professional accomplishments also include being recognized as an outstanding employee at Semnan Medical Sciences Health Center (2017-2019) and winning the Red Crescent First Aid Competition at Semnan University of Medical Sciences in 2018.

Research Interests 🔬

Zahra’s research focuses on designing and conducting epidemiological studies with a particular interest in infectious and non-communicable diseases. Her expertise includes cross-sectional, case-control, cohort studies, clinical trials, and vaccine studies. Additionally, she has specialized skills in multivariate analysis, survival analysis, and statistical software (SPSS and Stata).

Author Metrics 🏆

Zahra Barati has contributed to the field of epidemiology through various academic presentations, including poster and speaking engagements at the International Congress of Epidemiology, where she shared her research findings. Her work has been well-received within academic circles, highlighting her expertise in public health issues and infectious disease epidemiology. Her research outputs, particularly in the areas of bovine brucellosis and COVID-19, showcase her ability to conduct and interpret complex epidemiological studies, contributing valuable insights to the field. Zahra’s author metrics reflect her growing influence in epidemiology, as evidenced by her active participation in international conferences and scientific associations, with future publication opportunities anticipated as she continues to expand her research portfolio.

Publications Top Notes 📚
  1. “Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study”
    • Authors: Mehri, A., Sotoodeh Ghorbani, S., Farhadi-Babadi, K., Rahimi, E., Barati, Z., Taherpour, N., et al.
    • Journal: Journal of Intensive Care Medicine
    • Year: 2023
    • Volume and Issue: 38(9)
    • Pages: 825-837
    • Summary: This study systematically reviews and performs a meta-analysis on data regarding COVID-19 severity and mortality in Iran, identifying significant risk factors linked to adverse outcomes. The research synthesizes findings from multiple studies to provide insights on how demographic, health-related, and environmental factors impact COVID-19 outcomes, aiding in targeted public health interventions.
  2. “Bovine Brucellosis, Associated Risk Factors and Preventive Measures in Industrial Cattle Farms: A Case-Control Study”
    • Authors: Izadi, S., Moghaddas, V., Feizi, A., Bahreinipour, A., Barati, Z.
    • Journal: Heliyon
    • Year: 2024
    • Summary: This case-control study investigates the risk factors and preventative strategies for bovine brucellosis in industrial cattle farms. The paper provides a comprehensive analysis of management practices, environmental factors, and other variables that contribute to the incidence of brucellosis. The findings offer actionable recommendations for reducing infection rates and implementing effective control measures in cattle farms.

Conclusion

Zahra Barati stands out as a highly capable epidemiologist with a strong foundation in research, teaching, and leadership within her field. Her academic achievements, combined with her professional recognitions and technical expertise, make her an excellent candidate for the “Best Researcher Award.” To maximize her research impact and further her career, Zahra could focus on increasing her publication count, expanding her research scope, and seeking more international collaborations. Given her dedication and accomplishments, Zahra is well-positioned for this award and demonstrates great potential to continue contributing to public health and epidemiology.